Searching... Searching...
  • NVP + 0.53%
  • Köp 3.77
  • Sälj 3.78
  • Senast 3.77
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Equity research

2017-08-25

Company analysis by Edison:

R&D progress on track; new investor in board


2017-07-05

Company analysis by SeeThruEquity:

Update


2017-06-29

Company analysis by Edison:

Mitochondrial medicine specialist


2017-06-28

Company analysis by Analysguiden:

NeuroVive stärker handen 


2017-06-19

Company valuation report by Monocl:

NeuroVive Pharmaceutical


2017-02-16

Company analysis by BioStock:

NeuroVive Pharmaceutical


2016-12-05

Company analysis by SeeThruEquity:

Update


2016-12-02

Company analysis by Analysguiden:

Nystart lovande på sikt 


2016-09-21

Company analysis by SeeThruEquity:

Initiating Coverage


2016-09-16

Company analysis by Morningstar

Quantitative Equity Report


2016-06-13

Company analysis by Erik Penser

Clearer focus


2016-04-27

Bolagsanalys av BioStock

Analysuppdatering: NeuroVive Pharmaceutical 


2016-03-31

Bolagsanalys av Börshandlat:

Nyemission säkrar långsiktig finansiering 


2016-02-29

Bolagsanalys av Erik Penser:

Tar in nytt kapital 


2016-02-09

Bolagsanalys av, Analysguiden:

Skadeskjuten högoddsare 


 

Comments are closed.

IR Contact

Catharina Johansson

CFO

ir@neurovive.com

+46 (0) 46-275 62 21